Rules and regulations

How to Prepare for a Visit from the Drug Enforcement Agency (DEA) Regarding Buprenorphine Prescribing
Description: 
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source: 
PCSS
0
Your rating: None
Tags:
Sample Progress Notes
Description: 
Examples of how progress notes should be taken for buprenorphine patients.
Source: 
California Society of Addiction Medicine (CSAM)
4.5
Your rating: None Average: 4.5 (2 votes)
Tags:
Provider HIPAA Readiness Checklist
Description: 
Informational checklist designed to aid health care providers in making sure their practice is compliant with HIPAA regulations.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
4
Your rating: None Average: 4 (3 votes)
Tags:
Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for Maintenance and Detoxification Treatment
Description: 
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Syndicate content